WCLC 2025 - Posters & ePosters-P1.11.66 Cost-Effective Machine Learning for Predicting Survival in NSCLC Patients on Immunotherapy: Insights From the APOLLO11 Study

P1.11.66 Cost-Effective Machine Learning for Predicting Survival in NSCLC Patients on Immunotherapy: Insights From the APOLLO11 Study

Asset Subtitle

Vanja Miskovic

Meta Tag

Speaker Vanja Miskovic

Topic Metastatic Non-small Cell Lung Cancer – Immunotherapy